From KSQ Bets on CRISPR-Juiced Drug Discovery With $76M & Ex-Genzyme CEO:

KSQ CEO David Meeker

KSQ CEO David Meeker—

Underwriters and Partners

Xconomy Insight

Sponsored · Video
The Bay Area and Beyond: Biocom Talks Innovation and COVID
A Fireside Chat with Biocom President & CEO Joe Panetta
Biocom

Sponsored · Whitepaper
What’s Next in Neuroscience Therapies
New approaches & tech are on the horizon that could change how researchers and clinicians approach brain and neurological disorders

Sponsored · Whitepaper
How Big Is the US Market for Medical Devices & Technologies?
Knowing the volume of procedures and growth trends by site of care can allow you to understand the market demand for your product
IBM Watson

Xconomy on Demand

We offer a number of ways to subscribe for free!